REFERENCES
- Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Mul-ticenter AIDS Cohort Study, 1985-1992. Neurology. 1994; 44:1892–1900.
- McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet NeuroL 2005;4:543–555.
- Wulff EA, Wang AK, Simpson DM. HIV-associated periph-eral neuropathy: Epidemiology, pathophysiology and treat-ment. Drugs. 2000;59:1251–1260.
- Comblath DR, McArthur JC. Predominantly sensory neu-ropathy in patients with AIDS and AIDS-related complex. Neurology. 1988;38:794–796.
- Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: Assessment measures and risk factors. Neurology. 2006;66:1679–1687.
- Cherry CL, Skolasky RL, Lal L, et al. Antiretroviral use and other risks for HIV-associated neuropathies in an interna-tional cohort. Neurology. 2006;66:867–873.
- Lichtenstein KA, Armon C, Baron A, et al. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpa-tient study cohort. Clin Infect Dis. 2005;40:148–157.
- Lichtenstein KA, Armon C, Buchacz K, et al. Initiation of antiretroviral therapy at CD4 cell counts 350 cells/mm3 does not increase incidence or risk of peripheral neuropa-thy, anemia, or renal insufficiency. J Acquir Immune Defic Syndr 2008;47:27–35.
- Morgello S, Estanislao L, Simpson D, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: The Manhattan HIV Brain Bank. Arch NeuroL 2004;61:546–551.
- Smyth K, Affandi JS, McArthur JC, et al. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med. 2007;8:367–373.
- Ellis R, Evans SR, Clifford D, et al. Clinical validation of the neuroscreen. J NeuroyiroL 2005;11:503–511.
- Ebenezer GJ, Hauer P, Gibbons C, McArthur JC, Polydefkis M. Assessment of epidermal nerve fibers: A new diagnostic and predictive tool for peripheral neuropathies. J Neuro-pathol Exp NeuroL 2007;66:1059–1073.
- England JD, Gronseth GS, Franklin G, et al. Distal symmet-ric polyneuropathy: A definition for clinical research: Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurol-ogy. 2005;64:199–207.
- McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: Normative reference range and diagnostic efficiency. Arch Neurol. 1998;55: 1513–1520.
- Cornblath DR, Chaudhry V, Carter K, et al. Total neuropa-thy score: Validation and reliability study. Neurology. 1999; 53:1660–1664.
- Herrmann DN, Ferguson ML, Pannoni V, Barbano RL, Stan-ton M, Logigian EL. Plantar nerve AP and skin biopsy in sensory neuropathies with normal routine condition stud-ies. Neurology. 2004;63:879–885.
- Zhou L, Kitch DW, Evans SR, et al. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory poly-neuropathy. Neurology. 2007;68:2113–2119.
- Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001;56:257–260.